Spero Therapeutics Inc (NASDAQ:SPRO) has a beta value of 1.32 and has seen 1.01 million shares traded in the last trading session. The company, currently valued at $161.02M, closed the last trade at $2.88 per share which meant it lost -$0.05 on the day or -1.71% during that session. The SPRO stock price is -6.25% off its 52-week high price of $3.06 and 82.29% above the 52-week low of $0.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.74 million shares traded. The 3-month trading volume is 4.09 million shares.
The consensus among analysts is that Spero Therapeutics Inc (SPRO) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Spero Therapeutics Inc (NASDAQ:SPRO) trade information
Sporting -1.71% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the SPRO stock price touched $2.88 or saw a rise of 4.64%. Year-to-date, Spero Therapeutics Inc shares have moved 116.54%, while the 5-day performance has seen it change 1.05%. Over the past 30 days, the shares of Spero Therapeutics Inc (NASDAQ:SPRO) have changed 312.61%. Short interest in the company has seen 3.48 million shares shorted with days to cover at 0.35.
Spero Therapeutics Inc (SPRO) estimates and forecasts
The company’s shares have gained 189.51% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 17.67% over the past 5 years. Earnings growth for 2025 is a modest 9.45% while over the next 5 years, the company’s earnings are expected to increase by 7.97%.
SPRO Dividends
Spero Therapeutics Inc is expected to release its next earnings report on 2025-May-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Spero Therapeutics Inc (NASDAQ:SPRO)’s Major holders
Insiders own 24.61% of the company shares, while shares held by institutions stand at 23.25% with a share float percentage of 30.83%. Investors are also buoyed by the number of investors in a company, with Spero Therapeutics Inc having a total of 46.0 institutions that hold shares in the company. The top two institutional holders are ANSON FUNDS MANAGEMENT LP with over 3.75 million shares worth more than $4.88 million. As of 2024-06-30, ANSON FUNDS MANAGEMENT LP held 7.007% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.77 million shares as of 2024-06-30. The firm’s total holdings are worth over $2.3 million and represent 3.3079% of shares outstanding.
